Dr. Roque on the Importance of Biomarker Testing in Advanced Endometrial Cancer
Dario R. Roque, MD, discusses how biomarker testing can lead to more accurate and effective treatment selection in advanced endometrial cancer.
Darior Roque Pembrolizumab Keytruda Northwestern University Feinberg School Of Medicine Roberth Lurie Comprehensive Cancer Center Gynecologic Oncology Northwestern University
Source: onclive.com